Back

Pharma

8th Aseptic Processing: Compliance, Robotics & Automation

  • 21st – 22nd May 2026
  • Germany flag Germany Berlin

Demand for aseptic manufacturing is surging — and so are the challenges. With the revised EU GMP Annex 1, pharma companies must rethink processes, tech, and culture to stay compliant and efficient.

At the 8th Aseptic Processing Summit Berlin 2026, global experts will share how to build resilient, future-proof systems — from contamination control to digital tools and automation.

Explore the full agenda and insights in the #EAseptic brochure.

Read more

About the 8th Aseptic Processing: Compliance, Robotics & Automation Summit I #Easeptic 2026:

To be available soon…

Who should attend:

Chief Executives, Vice Presidents, Directors, Heads, Leaders, and Managers specialising in:

 

Manufacturing, Engineering & Operations

  • Experts in aseptic processing, parenterals, lyophilisation, HPAPI, and cleanroom management
  • Professionals in process science, production, maintenance, and facilities management
  • Leaders driving industrial automation, robotics, and engineering excellence

Quality, Safety & Compliance

  • QA/QC specialists ensuring rigorous standards in validation, cleaning, and environmental monitoring
  • Regulatory professionals navigating compliance with GMP and evolving Annex 1 requirements
  • Technical science experts advancing safety, product quality, and risk mitigation

Digital, Data & Emerging Tech

  • Innovators applying AI, VR, robotics, and digital twins to manufacturing and quality systems
  • Specialists in analytics, nanomaterials, and new technology integration
  • Teams exploring automation and smart data-driven process control

Product & Therapeutic Development

  • Leaders in mRNA, vaccines, medical devices, microbiology, formulation, and packaging technology
  • R&D and process innovators accelerating next-gen therapies and product pipelines

 

Register by 30th October - Get the Best Price! 

The Early Bird Offer expires in 11 days!

REQUEST A BROCHURE

To request an agenda for this Summit, please complete the details below. We will send you the agenda via email.

KEY PRACTICAL LEARNING POINTS

  • Annex 1 Best Practices in 2026 – Master the latest requirements for sterile medicinal product manufacturing and ensure compliance with evolving regulations.
  • Tech Innovation & Compliance – Adopt cutting-edge aseptic processing technologies while balancing regulatory expectations.
  • Inspection Preparedness – Avoid common pitfalls in GMP inspections and understand the future direction of aseptic GMPs.
  • Advanced Manufacturing – Tackle challenges in safe, high-potency production and integrate automation, robotics, AI, ML, VR, and predictive modeling.
  • Process & Facility Excellence – Design and implement efficient, compliant aseptic processes and facilities.
  • Contamination Control – Build robust strategies with the latest tools and technologies.
  • Next-Gen Therapies – Develop aseptic processes for ATMPs, including cell & gene therapies and mRNA vaccines.
  • Risk-Based Approaches – Apply modern risk frameworks to enhance process safety, efficiency, and sterility assurance.

 

Register by 30th October - Get the Best Price! 

The Early Bird Offer expires in 11 days!

Christa Myers, US

Sr. Fellow - Aseptic and Sterile Products

CRB

Christa Myers has been in the pharmaceutical industry for over 25 years and is a leader and subject matter expert. Christa is a well-recognized speaker at conferences and is frequently on-stage teaching others about regulatory requirements, operational issues and what to expect in the future of the in­dustry. Christa champions approaches that integrate strong project execution and technical solutions. Christa is on the steering committee for the ISPE community of practice for sterile products processing, a certified ISPE instructor of the sterile product processing baseline guide, the chair of ISPE’s women in pharma group, as well as an author of the most recent ISPE sterile processing baseline guide. Christa provides guidance and leadership to clients on how and when to utilise common or innovative solutions and continuously promotes the technical growth of people willing to learn more to advance the industry. She was recently awarded an honour as one of the 2019 Influential Women in Manufacturing.

James L. Drinkwater, DE

Head of GMP Compliance

Franz Ziel GmbH

James L. Drinkwater is the ex-chairman and an honorary member of the Pharmaceutical and Healthcare Sciences Society (PHSS), a not-for-profit educational platform for GxP and current leader of PHSS special interest groups on aseptic processing and biocontamination. He's the PHSS co-lead of Annex 1 revision (sterile medicinal product manufacturing) focus group and contamination control strategy (CCS) guidance initiative. James is also the current head of GMP compliance at Franz Ziel GmbH and actively involved in pharmaceutical, biologics, and ATMP product manufacturing as well as fill and finish projects. Based in the UK, James has a global support role and is also a qualified trainer on aseptic processing.

Richard Denk, CH

Senior Consultant, Aseptic Processing & Containment

Skan AG

Richard Denk has studied mechanical engineering and did an examination on experts of GMP, qualification and validation, pharmaceutical auditing, phar­maceutical engineering, and quality control at the University of Applied Sciences in Albstadt/Sigmaringen, Germany. Richard works at SKAN AG, headquartered in Allschwil, as the head of sales containment. He founded the expert con­tainment group of the ISPE DACH eight years ago. The containment group published the containment manual in September 2015. Richard has spent nearly 20 years working with highly active/highly hazardous substances and has developed the containment pyramid.

Alberto Gonzalez, ES

Global Sterility Assurance Associate Director

Takeda

Alberto is a pharmacist with 15 years of multinational experience in the pharma and biotech industries.

In his first roles he was responsible for Quality Assurance, Quality Systems and Quality Compliance for sterile products.

In his current position with Takeda’s Global Sterility Assurance and Microbiology team he has had a pivotal role on the company-wide implementation of Annex 1. His expertise lies with Aseptic Process Simulations, Contamination Control Strategies and application of Quality Risk Management to aseptic production. This can be summarized in his motto: “Think Aseptic”.

He is an invited speaker at industry conferences and is active in industry collaborations.

Christa Myers, US

Sr. Fellow - Aseptic and Sterile Products

CRB

James L. Drinkwater, DE

Head of GMP Compliance

Franz Ziel GmbH

Richard Denk, CH

Senior Consultant, Aseptic Processing & Containment

Skan AG

Alberto Gonzalez, ES

Global Sterility Assurance Associate Director

Takeda

BROCHURE 

Request the 8th Aseptic Processing brochure and find out the latest topics and ideas that will be shared.

Request

Please fill in your e-mail address below, and we will process your request shortly.

Please note that some of our emails may be marked as spam due to your company’s security settings. To ensure we stay in touch, you can also connect directly with Emma at [email protected]

What our
participants
are saying

This summit gave us clarity on how to implement Annex 1 updates without slowing production. The mix of regulatory insight and practical case studies was spot-on.

1
2
3
4
5

Markus

VP Manufacturing Operations

The level of expertise here is unmatched. From aseptic processing to digital automation, I left with strategies we could apply immediately across our GMP sites.

1
2
3
4
5

Sarah

Director of Quality Assurance

What I valued most was the networking — connecting with peers in CGT and aseptic processing opened doors to collaborations we’d never considered before.

1
2
3
4
5

Elena

Head of Process Development